Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology
Researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.